Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$123.8 - $132.96 $2.87 Million - $3.09 Million
-23,222 Reduced 87.96%
3,180 $393,000
Q1 2024

May 09, 2024

SELL
$113.24 - $131.95 $216,288 - $252,024
-1,910 Reduced 6.75%
26,402 $3.48 Million
Q4 2023

Feb 13, 2024

BUY
$100.18 - $109.02 $49,088 - $53,419
490 Added 1.76%
28,312 $3.09 Million
Q3 2023

Nov 09, 2023

BUY
$102.95 - $114.33 $62,593 - $69,512
608 Added 2.23%
27,822 $2.86 Million
Q2 2023

Aug 10, 2023

BUY
$108.61 - $118.38 $216,676 - $236,168
1,995 Added 7.91%
27,214 $3.14 Million
Q1 2023

May 11, 2023

SELL
$102.94 - $114.86 $11,426 - $12,749
-111 Reduced 0.44%
25,219 $2.68 Million
Q4 2022

Feb 09, 2023

BUY
$87.44 - $112.11 $26,232 - $33,633
300 Added 1.2%
25,330 $2.81 Million
Q3 2022

Nov 15, 2022

SELL
$84.53 - $94.96 $21,132 - $23,740
-250 Reduced 0.99%
25,030 $2.16 Million
Q2 2022

Aug 11, 2022

SELL
$83.49 - $94.64 $2,504 - $2,839
-30 Reduced 0.12%
25,280 $2.31 Million
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $34,549 - $38,728
470 Added 1.89%
25,310 $2.08 Million
Q4 2021

Feb 11, 2022

SELL
$72.28 - $90.54 $318,393 - $398,828
-4,405 Reduced 15.06%
24,840 $1.9 Million
Q3 2021

Nov 09, 2021

SELL
$71.68 - $78.83 $102,789 - $113,042
-1,434 Reduced 4.67%
29,245 $2.2 Million
Q2 2021

Aug 05, 2021

SELL
$70.31 - $77.77 $91,824 - $101,567
-1,306 Reduced 4.08%
30,679 $2.39 Million
Q1 2021

May 05, 2021

BUY
$68.86 - $81.11 $61,629 - $72,593
895 Added 2.88%
31,985 $2.47 Million
Q4 2020

Feb 01, 2021

SELL
$71.77 - $79.65 $26,913 - $29,868
-375 Reduced 1.19%
31,090 $2.54 Million
Q3 2020

Nov 03, 2020

BUY
$73.18 - $82.95 $95,499 - $108,249
1,305 Added 4.33%
31,465 $2.61 Million
Q2 2020

Jul 07, 2020

BUY
$70.42 - $80.13 $2.12 Million - $2.42 Million
30,160 New
30,160 $2.33 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $261B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Watchman Group, Inc. Portfolio

Follow Watchman Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Watchman Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Watchman Group, Inc. with notifications on news.